GABAergic Interneuron Cell Therapy for Drug-Resistant Epilepsy  

作　　者：Junzi Chen Zhongxia Li Yi Wang Liying Chen 

机构地区：[1]Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province,First Affiliated Hospital and School of Pharmaceutical Sciences,Zhejiang Chinese Medical University,Hangzhou,310053,China [2]Department of Pharmacy,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou,310016,China

出　　处：《Neuroscience Bulletin》2024年第5期680-682,共3页神经科学通报（英文版）

基　　金：supported by grants from the National Natural Science Foundation(82204350);the Natural Science Foundation of Zhejiang Province(Q22H309365 and LQ22H310007).

摘　　要：Epilepsy,one of the most common central nervous system disorders,affects about 70 million people of all ages worldwide[1].It is characterized by hyperactive neuronal networks,resulting from imbalanced excitatory and inhibitory activity.Despite the development of multiple next-generation anti-seizure medicines,one-third of epilepsy patients are still drug-resistant[2].

关 键 词：EPILEPSY THERAPY SEIZURE 

分 类 号：R338[医药卫生—人体生理学]